Patents Represented by Attorney Michael F. Borun
  • Patent number: 4810643
    Abstract: Disclosed are novel polypeptides possessing part or all of the primary structural conformation and one or more of the biological properties of a mammalian (e.g., human) pluripotent granulocyte colony-stimulating factor ("hpG-CSF") which are characterized in preferred forms by being the product of procaryotic or eucaryotic host expression of an exogenous DNA sequence. Sequences coding for part or all of the sequence of amino acid residues of hpG-CSF or for analogs thereof may be incorporated into autonomously replicating plasmid or viral vectors employed to transform or transfect suitable procaryotic or eucaryotic host cells such as bacteria, yeast or vertebrate cells in culture. Products of expression of the DNA sequences display, i.e., the physical and immunological properties and in vitro biological activities of isolates of hpG-CSF derived from natural sources. Disclosed also are chemically synthesized polypeptides sharing the biochemical and immunological properties of hpG-CSF.
    Type: Grant
    Filed: March 3, 1986
    Date of Patent: March 7, 1989
    Assignee: Kirin- Amgen Inc.
    Inventor: Lawrence M. Souza
  • Patent number: 4703008
    Abstract: Disclosed are novel polypeptides possessing part or all of the primary structural conformation and one or more of the biological properties of mammalian erythropoietin ("EPO") which are characterized in preferred forms by being the product of procaryotic or eucaryotic host expression of an exogenous DNA sequence. Illustratively, genomic DNA, cDNA and manufactured DNA sequences coding for part or all of the sequence of amino acid residues of EPO or for analogs thereof are incorporated into autonomously replicating plasmid or viral vectors employed to transform or transfect suitable procaryotic or eucaryotic host cells such as bacteria, yeast or vertebrate cells in culture. Upon isolation from culture media or cellular lysates or fragments, products of expression of the DNA sequences display, e.g., the immunological properties and in vitro and in vivo biological activities of EPO of human or monkey species origins.
    Type: Grant
    Filed: November 30, 1984
    Date of Patent: October 27, 1987
    Assignee: Kiren-Amgen, Inc.
    Inventor: Fu-Kuen Lin
  • Patent number: 4208388
    Abstract: The flowability of particulate lime is enhanced by treatment with effective amounts of selected fluid polymethylhydrogensiloxanes, polydimethylsiloxanes, and/or mixtures thereof.
    Type: Grant
    Filed: September 28, 1978
    Date of Patent: June 17, 1980
    Assignee: Dow Corning Corporation
    Inventor: William R. Nicholson